PeptideStack
5.2kquestions
20kanswers
220users

How many vial-days does a 2 mg vial give at 3.33 mg/mL on a weekly schedule?

Asked 8 Jan 2026Modified 4 months agoViewed 2.5k times
10

Details up front: 2 mg · 3.33 mg/mL.

This should be a straightforward calculation and I keep getting two different answers.

The numbers are arbitrary; the method is what I am after.

Can someone show the working rather than just the answer?

dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
cost-analysis
cost-analysis

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen,…

260 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
shareeditfollowflag
BB
askedbac_or_bust33k1378 Jan 2026

1 Answer

Accepted answer first, then by votes
8

Accepted answer

0.6 mL of solution, and the rest depends on your dose. A 2 mg vial reconstituted to 3.33 mg/mL occupies 2 ÷ 3.33 = 0.6 mL. At a 1 mg weekly dose that is 2 weeks; at 2.4 mg weekly it is 0 weeks — and both of those assume the vial contains its label claim, which is the assumption a content assay exists to test. Subtract one draw's dead space per dose: a few microlitres on a fixed-needle syringe, up to a hundred on a luer one.

Put another way, the arithmetic only stops being confusing once you work it through once and see that it is straightforward.

Rotation of injection site is a tolerability measure, not a pharmacokinetic one, but if you are going to do it you might as well do it right.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

Do not use the same needle to pierce the stopper and to administer. The tip is blunted by the stopper, and the hub now contains a dose you are about to lose to dead space anyway.

The Arrhenius relationship for drawing kinetics means that cold solution takes noticeably longer to draw than room-temperature solution.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

edited 8 Apr 2026 by oona_kekkonen — removed a claim I could not source

shareimprove this answerflag
OK
answered · acceptedoona_kekkonen13k171 Apr 2026
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.